Literature DB >> 22748835

Vascular endothelial growth factor and other angioglioneurins: key molecules in brain development and restoration.

José Vicente Lafuente1, Naiara Ortuzar, Harkaitz Bengoetxea, Susana Bulnes, Enrike G Argandoña.   

Abstract

Angioneurines are a family of molecules that include vascular growth factors such as VEGF, neurotrophins such as BDNF, IGF-I, and Erythropoietin, among others. They affect both neural and vascular processes. Due to the fact that all of them act over glia, we propose the term angioglioneurins to name them. They play a key role in the neurogliovascular unit that represents the functional core maintaining BBB. Although delivery to CNS is still an unsolved problem nowadays, exogenous angioglioneurin administration represents a promising therapeutic strategy for many neurological pathologies due to their neurotrophic and neurogenic role. In brains, VEGF is produced by neurons and astrocytes in different stages and situation, binding to tyrosine kinase receptors and also to neuropilin family. This fact reinforces its key role in the cross talk between neural and vascular development and activity. Angioglioneurins described in this report might become an important therapeutic resource in CNS restoration, especially in pathologies as stroke or traumatic brain injury.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748835     DOI: 10.1016/B978-0-12-386986-9.00012-0

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  8 in total

1.  Environmental Enrichment Reverses Tyrosine Kinase Inhibitor-Mediated Impairment Through BDNF-TrkB Pathway.

Authors:  Harkaitz Bengoetxea; Irantzu Rico-Barrio; Naiara Ortuzar; Ane Murueta-Goyena; José V Lafuente
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 2.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

Review 3.  Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells.

Authors:  Nienke Wagenaar; Caroline G M de Theije; Linda S de Vries; Floris Groenendaal; Manon J N L Benders; Cora H A Nijboer
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

4.  Neonatal systemic inflammation and the risk of low scores on measures of reading and mathematics achievement at age 10 years among children born extremely preterm.

Authors:  Alan Leviton; Olaf Dammann; Elizabeth N Allred; Robert M Joseph; Raina N Fichorova; T Michael O'Shea; Karl C K Kuban
Journal:  Int J Dev Neurosci       Date:  2018-02-02       Impact factor: 2.457

Review 5.  ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Authors:  Sighild Lemarchant; Mathilde Pruvost; Joan Montaner; Evelyne Emery; Denis Vivien; Katja Kanninen; Jari Koistinaho
Journal:  J Neuroinflammation       Date:  2013-10-31       Impact factor: 8.322

6.  Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.

Authors:  Mariska Sie; Wilfred F A den Dunnen; Harm Jan Lourens; Tiny G J Meeuwsen-de Boer; Frank J G Scherpen; Walderik W Zomerman; Kim R Kampen; Eelco W Hoving; Eveline S J M de Bont
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

7.  Increased physical activity is not enough to recover astrocytic population from dark-rearing. Synergy with multisensory enrichment is required.

Authors:  Harkaitz Bengoetxea; Naiara Ortuzar; Irantzu Rico-Barrio; José Vicente Lafuente; Enrike G Argandoña
Journal:  Front Cell Neurosci       Date:  2013-10-04       Impact factor: 5.505

8.  Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines.

Authors:  Walderik W Zomerman; Sabine L A Plasschaert; Sander H Diks; Harm-Jan Lourens; Tiny Meeuwsen-de Boer; Eelco W Hoving; Wilfred F A den Dunnen; Eveline S J M de Bont
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.